Assessing the impact of a safe and equitable biosimilar policy in the United States :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 2008.

Subjects

Generic drugs > Generic drugs / United States.
Pharmaceutical biotechnology > Pharmaceutical biotechnology / United States.
Biologicals > Biologicals / United States.

Note

Shipping list no.: 2008-0355-P.
"Serial no. 110-40."
Distributed to some depository libraries in microfiche.
Also available via Internet from the GPO Access web site. Address as of 5/14/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5F house%5Fhearings&docid=f:40500.pdf ; current access available via PURL.

Physical Description

vi, 184 p. : ill. ; 24 cm.

ISBN

0160808871
9780160808876

Locate a Print Version

Find in a library

Viewability